SCOPINARO, NICOLA
 Distribuzione geografica
Continente #
EU - Europa 32.681
AS - Asia 3.310
NA - Nord America 1.459
SA - Sud America 239
AF - Africa 40
OC - Oceania 7
Totale 37.736
Nazione #
IT - Italia 32.175
SG - Singapore 1.563
US - Stati Uniti d'America 1.361
CN - Cina 886
VN - Vietnam 450
FR - Francia 291
BR - Brasile 158
BD - Bangladesh 110
HK - Hong Kong 102
FI - Finlandia 65
JP - Giappone 41
DE - Germania 39
CA - Canada 36
AR - Argentina 31
MX - Messico 27
GB - Regno Unito 24
IQ - Iraq 23
CH - Svizzera 20
IN - India 20
ID - Indonesia 16
PK - Pakistan 14
EC - Ecuador 13
IE - Irlanda 13
PH - Filippine 12
CL - Cile 11
NL - Olanda 11
RU - Federazione Russa 10
TH - Thailandia 10
JM - Giamaica 9
VE - Venezuela 9
JO - Giordania 7
MA - Marocco 7
ZA - Sudafrica 7
LB - Libano 6
AU - Australia 5
CR - Costa Rica 5
DZ - Algeria 5
HN - Honduras 5
CO - Colombia 4
NP - Nepal 4
PE - Perù 4
PL - Polonia 4
PY - Paraguay 4
SA - Arabia Saudita 4
TW - Taiwan 4
UA - Ucraina 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
ES - Italia 3
ET - Etiopia 3
GR - Grecia 3
KE - Kenya 3
KZ - Kazakistan 3
NI - Nicaragua 3
RO - Romania 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
TR - Turchia 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
KR - Corea 2
LV - Lettonia 2
MN - Mongolia 2
MY - Malesia 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
SV - El Salvador 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
CZ - Repubblica Ceca 1
GF - Guiana Francese 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MT - Malta 1
NZ - Nuova Zelanda 1
PF - Polinesia Francese 1
PS - Palestinian Territory 1
Totale 37.731
Città #
Genova 19.791
Genoa 7.036
Rapallo 3.284
Vado Ligure 1.886
Singapore 786
San Jose 572
Lauterbourg 278
Ashburn 141
Ho Chi Minh City 135
Beijing 128
New York 117
Hanoi 102
Hong Kong 97
Helsinki 65
Santa Clara 45
Bordighera 39
Tokyo 36
Frankfurt am Main 33
Zurich 20
Los Angeles 19
Da Nang 18
Haiphong 18
Tianjin 17
Mexico City 16
Milan 16
Dublin 14
Dallas 13
Chicago 10
Orem 10
Amsterdam 9
Rome 9
San Francisco 9
São Paulo 9
Atlanta 8
Baghdad 8
City of London 8
Hải Dương 8
Phoenix 8
Toronto 8
Biên Hòa 7
Amman 6
Bologna 6
Buffalo 6
Can Tho 6
Chennai 6
Kingston 6
Montreal 6
Naples 6
Shanghai 6
Changsha 5
Dhaka 5
Lahore 5
New Delhi 5
Palermo 5
Pasadena 5
Sydney 5
Des Moines 4
Florence 4
Guayaquil 4
Jinan 4
Las Vegas 4
Manchester 4
Memphis 4
Ninh Bình 4
Oran 4
San José 4
Santiago 4
Tashkent 4
Turin 4
Điện Bàn 4
Addis Ababa 3
Asunción 3
Bangkok 3
Belo Horizonte 3
Brasília 3
Cairo 3
Caracas 3
Casablanca 3
Council Bluffs 3
Dakar 3
Damascus 3
Erbil 3
Joinville 3
Kansas City 3
Louisville 3
Managua 3
Nairobi 3
Nuremberg 3
Philadelphia 3
Porto Alegre 3
Quezon City 3
Quảng Ngãi 3
Quận Bình Thạnh 3
Scarborough 3
São Bernardo do Campo 3
Tegucigalpa 3
Tây Ninh 3
Wuhan 3
Zhengzhou 3
Abidjan 2
Totale 35.067
Nome #
Early reduction of matrix metalloproteinase-8 serum levels is associated with leptin drop and predicts diabetes remission after bariatric surgery 226
LA RESEZIONE GASTRICA CON GASTROENTEROANASTOMOSI SECONDO ROUX PER LA TERAPIA CHIRURGICA DELL'ULCERA GASTRICA E DUODENALE. 223
A 15-year evaluation of biliopancreatic diversion according to the Bariatric Analysis Reporting Outcome System (BAROS) 221
Biliopancreatic diversion for obesity: state of the art. 217
Biliopancreatic diversion 215
Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI <35 kg/m2. 214
Baseline neutrophil-to-lymphocyte ratio is associated with long-term T2D remission after metabolic surgery 212
Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver Damage 210
Type 2 Diabetes Remission and Control in Overweight and in Mildly Obese Diabetic Patients at Long-Term Follow-Up After Biliopancreatic Diversion 207
Effect of biliopancreatic diversion on hypertension in severely obese patients. 205
A comparison of a personal series of biliopancreatic diversion and literaturedata on gastric bypass help to explain the mechanisms of resolution of type 2diabetes by the two operations. 202
Alexithymia and eating behaviour in severely obese patients. 196
Bariatric surgery in adolescents: a long-term follow-up study 196
Biliopancreatic diversion for obesity at eighteen years 195
Tissue specificity in fasting glucose utilization in slightly obese diabetic patients submitted to bariatric surgery. 195
Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies. 192
Beta-cell function improvement after biliopancreatic diversion in subjects withtype 2 diabetes and morbid obesity. 191
Physical Activity After Surgically Obtained Weight Loss: Study with a SenseWear Armband in Subjects Undergoing Biliopancreatic Diversion 189
BILIO-PANCREATIC BYPASS FOR OBESITY: II. INITIAL EXPERIENCE IN MAN. 188
10 YEARS EXPERIENCE WITH BILIOPANCREATIC DIVERSION (BPD) 188
High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion 187
The long-term impact of biliopancreatic diversion on glycemic control in the severely obese with type 2 diabetes mellitus in relation to preoperative duration of diabetes. 182
Interdisciplinary European guidelines on metabolic and bariatric surgery. 178
Three-factor Eating Questionnaire and Eating Disorder Inventory in the evaluation of psychological traits and emotional reactivity in obese patients 177
Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss. 176
Type 2 diabetes and weight loss following biliopancreatic diversion for obesity. 175
[A case of severe obesity treated jejunoileal bypass. 1-year clinical course]. 170
[Role of carbohydrates in the diet of gout patients]. 169
Biliopancreatic diversion reduces QT interval and dispersion in severely obese patients. 168
Colorectal cancer after biliopancreatic diversion for obesity 167
Role of preoperative Multitest findings on predicting postoperative infectiouscomplications. 165
A new approach to the fashioning of the gastroenteroanastomosis in laparoscopicstandard biliopancreatic diversion. 161
CLINICAL USE OF PARTIAL BILIOPANCREATIC BYPASS FOR OBESITY. DETAILS OF OPERATIVE TECHNIQUE AND FOLLOW-UP MANAGEMENT. 161
Three factor eating questionnaire and eating disorder inventory in the evaluation of psychological traits and emotional reactivity in obese persons 159
Does Biliopancreatic Diversion Carry Increased Risk for Colorectal Cancer? A Cohort Study 158
[Aspects ofneurohypophysial function in the course of hyperthyroidism]. 158
'Simple' form of Caroli's disease 157
[Behavior of plasma insulin and GIP in obese patients subjected tobiliopancreatic bypass]. 157
Effects of Gastric Bypass on Type 2. Diabetes in Patients with BMI 30 to 35 157
Prediction of Diabetes Remission at Long Term Following Biliopancreatic Diversion 157
Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35 157
Thirteen years of follow-up in patients with adjustable silicone gastric banding for obesity: weight loss and constant rate of late specific complications. 155
Leptin and HDL-cholesterol in non-diabetic normotensive subjects. 155
The Effects of Biliopancreatic Diversion on Type 2 Diabetes Mellitus in Patients with Mild Obesity (BMI 30-35 kg/m2) and Simple Overweight (BMI 25-30 kg/m 2) A Prospective Controlled Study. 155
Gastric cancer and Roux-en-Y gastric bypass. 153
[Action of parathormone on the urinary excretion of mono- and bivalent cations in man]. 153
Quality of life in obese subjects following biliopancreatic diversion. 152
Are BPD subjects at increase risk of colon cancer? 152
WERNICKE-KORSAKOFF ENCEPHALOPATHY FOLLOWING BILIOPANCREATIC DIVERSION 152
Sub-clinical organ damage in hypertension and obesity 151
. A late complication of Hickman right atrial catheter 149
[Behavior of serum proteins and lipids after jejuno-ileal bypass for obesity]. 148
Serum leptin concentration in obese patients with binge eating disorder. 148
Energy and nitrogen absorption after biliopancreatic diversion 148
Serum levels of osteopontin predict diabetes remission after bariatric surgery 148
Preoperative resting energy expenditure does not predict weight loss and maintenance after vertical banded gastroplasty. 147
BILIOPANCREATIC DIVERSION 147
Interdisciplinary European guidelines for surgery for severe (morbid) obesity. 147
[Behavior of urinary excretion of monoand bi-valent cations after intravenous overload of calcium]. 146
[Automated determination of total nitrogen in urine and feces]. 146
Insulin-like growth factor-I in human malnutrition: relationship with some body composition and nutritional parameters. 145
Orally-administered Serum Ranitidine Concentration after BiliopancreaticDiversion for Obesity. 145
Changes in serum ghrelin concentration following biliopancreatic diversion for obesity. 144
Biliopancreatic Diversion. 144
Radiology of patients with vertical banded gastroplasty. 144
BEHAVIORAL APPROACH TO PROMOTE EATING HABITS AND LIFESTYLE CHANGES FOLLOWING GASTRIC CHANGES FOR OBESITY 143
Short-term liver function after biliopancreatic diversion. 143
Intraluminal penetration of the band in patients with adjustable silicone gastricbanding: radiological findings. 142
Binge eating in massively obese patients undergoing bariatric surgery. 142
Thirty-five years of biliopancreatic diversion: notes on gastrointestinal physiology to complete the published information useful for a better understanding and clinical use of the operation. 142
Relationships of serum leptin to clinical and anthropometric findings in obese patients. 141
Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity 141
Resting Energy Expenditure in long-term postobese subjects after weight normalization by dieting or biliopancreatic diversion 140
Night eating in obesity: a descriptive study. 140
Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35kg/m2: an integrative review of early studies. 139
Long-term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non-morbidly obese patients. 139
Biliopancreatic diversion. 138
Bariatric surgery in adolescents: A very long-term follow-up survey after biliopancreatic diversion (BPD) 138
Why the Operation I Prefer is Biliopancreatic Diversion (BPD). 137
Editors' comment: bariatrics and diabetes meta-analysis. 137
Eating Disorder Inventory in the assessment of psychosocial status in the obese patients prior to and at long term following biliopancreatic diversion for obesity 137
Body composition and energy expenditure in obese patients prior to and following biliopancreatic diversion for obesity. 136
Intravenous nutritional support in pregnancy. Experience followingbiliopancreatic diversion. 136
Interdisciplinary European Guidelines on metabolic and bariatric surgery 136
[Behavior of the serum electrolytes after jejuno-ileal bypass for obesity]. 135
[Urinary excretion of oxalate after bilio-pancreatic bypass for obesity]. 135
Magnetic resonance spectroscopy facilitates assessment of intramyocellular lipid changes: a preliminary short-term study following biliopancreatic diversion. 135
[Behavior of plasma pancreatic polypeptides and motilin in obese patientssubjected to biliopancreatic bypass]. 134
liver morphology and function after biliopancreatic bypass 134
BONE HISTOMORPHOMETRY AND VITAMIN D STATUS AFTER BILIOPANCREATIC BYPASS FOR OBESITY. 133
[Behavior of plasma enteroglucagon and neurotensin in obese patients subjected tobiliopancreatic bypass]. 133
[2 cases of death caused by hepatic insufficiency after jejuno-ileal bypass forobesity]. 133
Can a protocol for glycaemic control improve type 2 diabetes outcomes aftergastric bypass? 133
Pregnancy in Formerly Type 2 Diabetes Obese WomenFollowing Biliopancreatic Diversion for Obesity 132
Pregnancies in an 18-year follow-up after biliopancreatic diversion 132
INTRALUMINAL PENETRATION OF THE BAND IN PATIENTS WITH ADJUSTABLE SILICONE GASTRIC BAMDING: REDIOLOGICAL FINDINGS 131
Night eating and binge eating disorder in obese patients. 131
Obese binge eaters: metabolic characteristics, energy expenditure and dieting 130
Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and cardiovascular parameters. 130
In vivo evaluation of immunological status after biliopancreatic bypass. 130
Totale 15.920
Categoria #
all - tutte 113.998
article - articoli 110.606
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.392
Totale 227.996


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021137 0 0 0 0 0 0 0 0 0 0 0 137
2021/20223.753 66 358 226 525 162 204 295 814 132 373 96 502
2022/20233.930 420 178 27 432 628 784 8 380 655 22 335 61
2023/20241.592 103 227 18 185 114 346 38 82 83 48 117 231
2024/20254.605 101 383 174 263 661 482 442 707 182 227 396 587
2025/20267.818 936 181 508 727 936 893 1.430 309 544 773 518 63
Totale 37.803